For research use only. We do not sell to patients.

CCT244747

CAS No. : 1404095-34-6

Biological Activity：CCT244747 is a potent, orally bioavailable and highly selective CHK1 inhibitor, with an IC₅₀ of 7.7 nM; CCT244747 also abrogates G2 checkpoint with an IC₅₀ of 29 nM.

Research Area：Cancer

Targets：Checkpoint Kinase (Chk)

Related Screening Libraries:Bioactive Compound Library Plus;Cell Cycle/DNA Damage Compound Library;Kinase Inhibitor Library;Anti-Cancer Compound Library;Anti-Aging Compound Library;Orally Active Compound Library;Chemical Probe Library;Anti-Lung Cancer Compound Library;Cancer Stem Cells Compound Library;

Related Small Molecules:VER-00158411;BML-277;CHK1-IN-3;GDC-0425;PF 477736;SCH900776;SAR-020106;Prexasertib;CHK1-IN-2;Chk1-IN-6;Monalizumab;CCT241533 dihydrochloride;MRT00033659;CHK1 inhibitor;SB-218078;Chk2-IN-1;CHK1-IN-4;Zn-DPA-maytansinoid conjugate 1;CCT245737;CHIR-124;GDC-0575 dihydrochloride;CHK-IN-1;PD 407824;AZD-7762;Rabusertib

About Us:

MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
Structurally and synthetically diverse biologically active compounds；
roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；

Structurally and synthetically diverse biologically active compounds；

Customized order volume ranging from milligrams to kilograms scale；

We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.

Top Publications Citing Use of MCE Products